2024年4月4日 · Nonalcoholic fatty liver disease, often called NAFLD, is a liver problem that affects people who drink little to no alcohol. In NAFLD, too much fat builds up in the liver. It is seen most often in people who are overweight or obese.

2024年4月4日 · This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.

2024年4月4日 · This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.

2024年4月4日 · This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.

2023年2月11日 · Being obese increases your risk of conditions that may lead to cirrhosis, such as nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Having viral hepatitis.

Nonalcoholic fatty liver disease, often called NAFLD, is a liver problem that affects people who drink little to no alcohol. In NAFLD, too much fat builds up in the liver. It is seen most often in people who are overweight or obese.

2024年4月4日 · La enfermedad no alcohólica de hígado graso, también llamada hepatopatía grasa no alcohólica, es un problema hepático que afecta a personas que beben poco o nada de alcohol. En la enfermedad no alcohólica de hígado graso, hay mucha acumulación de grasa en este órgano. Se observa con mayor frecuencia en personas con sobrepeso u obesidad.

2024年2月13日 · Fat that builds up in the liver, called nonalcoholic fatty liver disease or metabolic-associated steatotic liver disease. Certain prescription or other medicines.

2023年11月9日 · Drinking alcohol destroys liver cells. Alcoholic hepatitis most often happens in people who drink heavily over many years. But the link between drinking and alcoholic hepatitis isn't simple. Not all heavy drinkers get alcoholic hepatitis. And some people who drink much less get the disease.

2020年5月26日 · Some individuals with NAFLD can develop nonalcoholic steatohepatitis (NASH), an aggressive form of fatty liver disease, which is marked by liver inflammation and may progress to advanced scarring (cirrhosis) and liver failure.